Description
In vitro activity of new antimicrobial agents
David Felmingham, Director, GR Micro Ltd, London, UK
David Felmingham, Director, GR Micro Ltd, London, UK
The development of new antimicrobials is driven by
various factors including:
1. to overcome resistance to current compounds,
2. to improve pharmacokinetic/pharmacodynamic
characteristics, and
3. to reduce side effect/toxicity problems.
